# Lifetech CeraFlex™ Post-Market Surveillance Study

> **NCT02621528** · NA · COMPLETED · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Patent Foramen Ovale
- Atrial Septal Defect
- Patent Ductus Arteriosus

## Interventions

- **DEVICE:** CeraFlex

## Key facts

- **NCT ID:** NCT02621528
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2019-01
- **Final completion:** 2020-02
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621528, "Lifetech CeraFlex™ Post-Market Surveillance Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02621528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*